Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21972452 | 0.93 | PDK2 (0.32) | PDK2 | |
| SCHEMBL27111677 | 0.92 | PDK2 (0.33) | PDK2 | |
| SCHEMBL19394080 | 0.91 | PDK2 (0.34) | PDK2 | |
| SCHEMBL25125227 | 0.90 | PDK2 (0.35) | PDK2 | |
| SCHEMBL23307407 | 0.90 | PDK2 (0.33) | PDK2 | |
| SCHEMBL24255907 | 0.89 | PDK2 (0.37) | PDK2 | |
| SCHEMBL23307677 | 0.89 | PDK2 (0.31) | PDK2 | |
| SCHEMBL19394123 | 0.89 | PDK2 (0.33) | PDK2 | |
| SCHEMBL20823219 | 0.87 | — | — | |
| SCHEMBL21662296 | 0.87 | PDK2 (0.36) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| WO-2020159019-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SLC25A21, PIEZO1, SLCO4C1 | PDK2 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.